Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2005; 45:326-327, doi:10.1016/j.jacc.2004.10.024
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wheatley, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wheatley, G. H., III

LETTERS TO THE EDITOR

Cardiologist in the carotids

Grayson H. Wheatley, III, MD*

* Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern, 5939 Harry Hines Boulevard, HA-9, Suite 135, Dallas, TX 75390-8879

(Email: gwheat{at}parknet.pmh.org).


I read with interest the viewpoint by Dr. Gray (1), which reviews the case for carotid stenting. As an emerging technology, carotid stenting can be an important therapeutic modality for high surgical risk patients, and has the potential for expanded applications in additional patient groups.

What is the cardiac surgeon's role in the development and dissemination of carotid stents? Should one specialty alone be a gatekeeper for the introduction and performance of new endovascular procedures? Dr. Gray argues that cardiologists should be at the forefront of the wave to deploy endoluminal stents for carotid artery disease owing to their familiarity with complex percutaneous interventional procedures, and their ability to manage carotid-body–related medical issues. Cardiac and vascular surgeons are similarly capable of performing the technically demanding skills involved in carotid stenting, and they are also qualified to handle the postprocedure medical sequelae. Cardiac and vascular surgeons, in contrast to cardiologists, are capable of managing life-threatening and device-related surgical complications. However, catheter-based skills are absent from the curriculum of most cardiac surgery training programs. Hence, a majority of graduating and practicing cardiac surgeons lack the necessary skills to routinely incorporate endovascular procedures into their practice.

Cardiac surgeons, cardiologists, interventional radiologists, and vascular surgeons should unite to develop multispecialty endovascular training programs and determine national credentialing standards for carotid stenting. Moreover, cardiac surgeons must take advantage of this opportunity to address the broader issue of endovascular training within our specialty. Vascular surgery has already incorporated endovascular experiences into their training regimens. As a result, many graduating vascular surgery residents possess catheter-based skills and are engaged in the practice of "endovascular surgery." The American Board of Thoracic Surgery should consider adding an endovascular component to the graduating certification requirements. Cardiac surgeons can currently obtain training in catheter-based procedures only through a limited number of nonaccredited fellowships. If cardiac surgeons are to be realistically involved in catheter-based procedures (and they should), it is time that cardiac surgery training programs either: 1) add individuals to their faculty with advanced endovascular skills; 2) encourage existing faculty to retrain in catheter-based procedures; or 3) allow their residents to spend quality time during their residency with clinicians who have extensive endovascular experience.

Who performs carotid stenting is a highly charged issue, and perhaps it will be the sentinel event that can bring diverse specialties together to create a national standard for training and credentialing in endovascular procedures. I believe the optimal solution will be a multidisciplinary based approach, so that qualified physicians from a number of specialties will be able to offer carotid stenting to their patients. Working through these issues now will also potentially make the introduction and dissemination of newer catheter-based therapies, such as percutaneous valves and cellular therapies for heart failure, more straightforward and less contentious.


    References
 Top
 References
 
1. Gray WA. A cardiologist in the carotids J Am Coll Cardiol 2004;43:1602-1605.[Abstract/Free Full Text]





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wheatley, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wheatley, G. H., III

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement